Excellagen®

Excellagen® is an Advanced, Wound Care Management Platform

For professional use only; designated as “skin substitutes” per CMS. MAC reimbursement process

• Formulated fibrillar Collagen (2.6%) Wound Conforming Matrix

• High molecular weight

excelbooth6
Excellagen_Box0.8-1

Excellagen® Highlights

Excellagen® is FDA 510(K) cleared for 17 wound types

Intellectual properties and global rights of Excellagen® except China, Russia and CIS

R&D company spent over $20 million prior to approval

Received Patent on October 10, 2017

Has a unique Healthcare Common Procedure Coding System (HCPCS) Code – Q4149 https://hcpcs.codes/q-codes/Q4149/

Clinical data show significant tissue growth, accelerated healing response and positive wound closure

Safe and effective

No mixing, no sutures, no staples, no thawing

Over $20 million invested and completed

Viscosity optimized for dripless wound coverage

Wound Conforming Matrix that completely covers the wound bed and fills all voids

Pre-filled, ready to use syringes with flexible applicator tips

Three syringe sizes: 0.5cc, 0.8cc and 3.0cc to cover a variety of wound sizes

Refrigerated storage

Treatment at only one-week intervals

Immediately activates human platelets triggering release of Platelet-Derived Growth Factor (PDGF) a key

Accelerates granulation tissue growth in “non-healing wounds”

Excellagen® is categorized as Cellular and/or Tissue Based Product (CTP)

Excellagen® Highlights

Excellagen_Box0.8-1

Excellagen® is FDA 510(K) cleared for 17 wound types

Intellectual properties and global rights of Excellagen® except China, Russia and CIS

R&D company spent over $20 million prior to approval

Received Patent on October 10, 2017

Has a unique Healthcare Common Procedure Coding System (HCPCS) Code – Q4149 https://hcpcs.codes/q-codes/Q4149/

Clinical data show significant tissue growth, accelerated healing response and positive wound closure

Safe and effective

No mixing, no sutures, no staples, no thawing

Over $20 million invested and completed

Viscosity optimized for dripless wound coverage

Wound Conforming Matrix that completely covers the wound bed and fills all voids

Pre-filled, ready to use syringes with flexible applicator tips

Three syringe sizes: 0.5cc, 0.8cc and 3.0cc to cover a variety of wound sizes

Refrigerated storage

Treatment at only one-week intervals

Immediately activates human platelets triggering release of Platelet-Derived Growth Factor (PDGF) a key

Accelerates granulation tissue growth in “non-healing wounds”

Excellagen® is categorized as Cellular and/or Tissue Based Product (CTP)

Additionally,

Excellagen has can serve as an Enabling Delivery Platform for pluripotent stem cells, antimicrobial agents, small molecule drugs, DNA-Based Biologics, conditioned cell media and peptides.

Products
Print

Mission

Future products focusing on innovative therapies in bone and joint regeneration comprise current pipeline. The company’s mission is to become a significant force in regenerative medicine and Innovate the Science of Healing.

Print

 

Mission

Future products focusing on innovative therapies in bone and joint regeneration comprise current pipeline. The company’s mission is to become a significant force in regenerative medicine and Innovate the Science of Healing.

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4